Inspire Medical Systems, Inc. Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount
Inspire Medical Systems, Inc. (INSP) reported Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount · last filed 2026-08-03
- Inspire Medical Systems, Inc. equity securities without readily determinable fair value, upward price adjustment, annual amount for the quarter ending 2026-06-30 was $300.00K.
| Period end | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 6 month |
|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-03 | $300.00K 10-Q · filed 2026-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |